Chronic alcohol-related neuroadaptations in key neural circuits of emotional and cognitive control play a critical role in the development of, and recovery from, alcoholism. Converging evidence in the neurobiological literature indicates that neuroplastic changes in the prefrontal–striatal–limbic circuit, which governs emotion regulation and decisionmaking and controls physiological responses in the autonomic nervous system and hypothalamic–pituitary–adrenal axis system, contribute to chronic alcoholism and also are significant predictors of relapse and recovery. This paper reviews recent evidence on the neuroplasticity associated with alcoholism in humans, including acute and chronic effects, and how these neurobiological adaptations contribute to alcohol recovery, along with the discussion of relevant clinical implications and future research directions.
Recovery from alcoholism is a complex and long-term process with high relapse rates. Therefore, understanding why people relapse has been critically important to improving treatment outcomes. To that end, researchers are looking for clinical and biological markers that predict relapse after treatment and to use those risk factors to develop effective treatments to reduce relapse rates. One promising research area is examining how alcohol changes structure and function in the brain, affecting what neuroscience calls neuroplasticity and causing neuroadaptations that can affect the brain’s reward and decision-making centers and, in turn, affect relapse and recovery.
During recovery, individuals with alcohol use disorder (AUD) psychologically and physiologically recuperate from the deleterious effects of alcohol exposure by achieving complete abstinence or low-level, nonhazardous alcohol intake. The National Epidemiologic Survey of Alcohol-Related Conditions (NESARC) conducted 43,093 in-person interviews with a national sample of adults and found that 4,422 subjects, at some point prior to the past year, met the criteria for alcohol dependence, as defined by the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM–IV). According to the survey, during the preceding year, of those 4,422 alcohol-dependent people, 35.9 percent achieved either low-risk drinking (17.7 percent) or abstinence (18.2 percent) (Dawson et al. 2005). The study also noted that recovery rates tend to be even lower in clinical samples of people with severe dependence and for people with lifetime dependence or at high risk of relapse (Dawson et al. 2005). Additionally, the risk of relapse after treatment for AUD increases if people have concurrent conditions, such as anxiety or stress sensitivity (Kushner et al. 2005; Sinha et al. 2011).
In an effort to identify clinical and biological markers that predict relapse risk, researchers have looked toward the brain and alcohol-related changes in the brain that might make it more difficult for people with AUD to recover successfully. In particular, recent research has capitalized on advances in neuroimaging techniques to examine neuroplastic changes that may increase vulnerability to alcoholism and alcohol relapse (Buhler and Mann 2011). In fact, evidence suggests that chronic, heavy alcohol consumption is related to neuronal changes that target critical central nervous system (CNS) functions governing homeostasis, emotion regulation, and decisionmaking. These changes, in turn, may make it significantly more challenging for people to stop drinking and may result in various comorbid, psychological, and physiological symptoms (Bechara 2005; Breese et al. 2011). For instance, when people with AUD are abstinent, altered neural circuits of stress and reward modulation make them highly sensitive to stress and increase alcohol craving and other withdrawal symptoms, including anxiety, negative emotion, autonomic nervous system (ANS) disruption, fatigue, and sleep problems (Breese et al. 2011; Seo and Sinha 2014).
These chronic alcohol-related neuronal changes and their co-occurring symptoms, such as stress, may serve as markers of alcohol relapse and long-term recovery but are not currently addressed in most AUD treatment programs. Already there is evidence that people who maintain long-term abstinence show functional differences in resting-state brain synchrony relative to those with short-term abstinence (Camchong et al. 2013).
This paper reviews the evidence for neuronal changes associated with alcoholism in humans, including those resulting from acute and chronic effects of alcohol, and how these changes contribute to alcohol relapse. To help understand alcohol recovery in a clinical research setting, the review will specifically focus on neuroplastic changes associated with alcohol relapse immediately following treatment. This paper also reviews the effects of stress on alcohol-related neuroplasticity and alcohol recovery, along with relevant clinical implications and future research directions. Elucidating the link between neuroplastic changes and alcohol recovery will contribute to our understanding of complex alcohol-related symptomatology and provide insights into the development of effective treatments to improve recovery from alcoholism.
Neuroplastic Changes in the PSL Circuit
Neuroplasticity refers to changes in the nervous system that occur in response to various stimuli or experiences and include structural and functional re-organization (Sale et al. 2014). These neuroplastic changes can be acute or take place over time (Sale et al. 2014) and can either be positive or negative, depending on the experience (Vance and Wright 2009). Neuroplastic changes in response to alcohol or other addictive substances are most commonly regarded as negative neuroplasticity associated with suboptimal functioning and maladaptive behaviors (Kalivas and O’Brien 2008). Addiction researchers frequently use the term “neuroadaptation” when referring to alcohol- or drug-related neuroplastic changes in the CNS (Breese et al. 2011; Cohen 2003; Shaham and Hope 2005). Thus, the addiction neuroscience literature uses the concepts of neuroadaptation and neuroplasticity interchangeably.
In studies of alcoholism, substantial evidence indicates short-term and long-term pharmacological effects of alcohol on the nervous system and related neurophysiological dysfunction (Seo and Sinha 2014). Specifically, research has well documented acute and chronic alcohol-related neuroadaptations in the prefrontal–striatal–limbic (PSL) circuit, which helps modulate motivation and emotion (Buhler and Mann 2011). The circuit consists of the striatal-limbic system, which is involved in the brain’s reward system in the striatum, and its stress system, in the amygdala; and the prefrontal regulatory region, which includes the medial prefrontal cortex (PFC), the anterior cingulate cortex (ACC), the orbitofrontal cortex (OFC), and the dorsolateral PFC. As a whole, the PSL circuit plays a pivotal role in modulating reward, stress, and decision-making throughout the course of alcoholism, including the disorder’s initial development, alcohol dependence, uncontrollable alcohol seeking, and continued alcohol relapse despite its negative consequences (Seo and Sinha 2014).
One way this circuit could interact with alcohol to influence these phases of alcoholism is through a part of the PSL circuit called the ventromedial prefrontal cortex (VmPFC), a brain region critical for emotional and behavioral control and that regulates the ANS and hypothalamic–pituitary–adrenal (HPA) axis systems (Radley 2006). If repeated alcohol use disturbs the VmPFC, it could disrupt the regulation and homeostasis of ANS and HPA axis system functioning, which can result in high physiological and emotional arousal, and, in turn, is associated with high alcohol craving (Sinha et al. 2009). Continued chronic alcohol-related changes in the PSL circuit could place individuals in a neurobiologically vulnerable state, substantially compromising their ability to control the urge to drink heavily and increasing the risk that they will resume drinking after a period of abstinence. For this reason, researchers have suggested that maintaining an intact PSL circuit is critical to a person’s ability to overcome alcohol seeking and relapse urge (Koob 2009; Seo and Sinha 2014; Sinha 2008). Thus, understanding acute and chronic neuroadaptive patterns in the course of alcohol illness, especially in the PSL circuit, may provide insights into alcohol-related clinical symptoms, emotional and behavioral changes, and the potential impact of these patterns on alcohol recovery.
Acute Effects of Alcohol on Brain Response
Alcohol has clear and immediate pharmacological effects on the brain (see for example, Wallner and Olsen 2008). Specifically, neuroimaging studies of acute alcohol consumption in healthy social drinkers find specific effects on emotional processing and modulation (Gilman et al. 2008), cognitive disruption (Soderlund et al. 2007), and decisionmaking (Gilman et al. 2012).
In relation to emotional processing and modulation, several functional magnetic resonance imaging (fMRI) studies report acute effects of alcohol on reducing anxious and negative emotion and increasing alcohol craving by modulating limbic-striatal activity. In one study (Gilman et al. 2008), researchers administered an intoxicating dose of alcohol to healthy individuals via intravenous injection and found they had reduced limbic response to fearful faces and increased striatal activity. In another study (Sripada et al. 2011), researchers found decreased activity in the amygdala when 12 healthy but heavy social drinkers ingested alcohol and then viewed socioemotional stimuli, including fearful/angry faces. Another study (Gorka et al. 2013), using the same study sample and design, found that drinking alcohol reduced the connectivity between the amygdala and orbitofrontal cortex, suggesting that the regulatory part of the brain is interacting less with the amygdala during the processing of socioemotional stimuli under the influence of alcohol. When a different group of healthy but heavy social drinkers received an alcohol taste cue, researchers saw increased activity in the VmPFC, the ACC, and the ventral striatum (Filbey et al. 2008). Consistent with this, researchers saw enhanced activity in regions of the ventral and dorsal striatum in healthy male social drinkers asked to imagine an alcohol cue–related situation, with a significant correlation between alcohol craving and activity in these regions (Seo et al. 2011).
Several fMRI studies also have reported an influence of alcohol on cognitive function and decisionmaking. Alcohol consumption in healthy individuals resulted in impaired episodic memory encoding, which, in turn, was associated with reduced activity in the lateral PFC (Soderlund et al. 2007). In addition, during a decision-making task, acute alcohol administration via intravenous injection increased risk-taking behaviors, increased striatal reactivity to risk choices, and blunted brain response to emotional feedback related to both winning and losing (Gilman et al. 2012).
Taken together, neuroimaging studies demonstrate the significant influence of alcohol in healthy individuals via alterations in the PSL circuit, including reduced limbic response to negative emotional stimuli (Gilman et al. 2008; Sripada et al. 2011), enhanced striatal response to rewarding stimuli (Filbey et al. 2008; Gilman et al. 2008; Seo et al. 2011) and to risky decision- making (Gilman et al. 2012), and impaired episodic memory functioning (Soderlund et al. 2007). These studies clearly point to the PSL circuit as a critical early target of alcohol effects and its potential, deleterious impact on neuroplasticity with chronic alcohol abuse.
Neuroadaptations, Chronic Alcoholism, and Recovery
Not surprisingly, just as acute alcohol consumption affects the brain, so does chronic, heavy alcohol consumption. In fact, studies consistently report alcohol-related neuroadaptive changes in the PSL circuit, along with related allostatic changes in physiological functions, including ANS and HPA axis systems (Breese et al. 2011; Seo and Sinha 2014). The brain regions affected include the reward system, the stress system, and the prefrontal regulatory system (Seo and Sinha 2014).
Reward System Dysfunction and Alcohol Recovery
Several lines of research link changes in the striatum and, therefore, the brain’s reward system to chronic alcohol use:
- Blunted dopamine release and other types of dopamine dysfunction in the striatum may be a biomarker indicating increased vulnerability to alcohol and other substance use (Trifilieff and Martinez 2014);
- Chronic alcohol abuse and exposure result in alterations in reward brain regions, such as the ventral striatum, leading to disrupted dopamine transmission and striatal activity (Martinez et al. 2005; Seo and Sinha 2014; Volkow et al. 2002);
- Detoxified AUD patients show signs of altered reward responses, such that enhanced ventral striatal activity is more biased toward alcohol cues than other reward cues, such as money (Wrase et al. 2007); and
- People with AUD had reduced levels of dopamine D2 receptors in their frontal-striatal regions compared with control subjects (Volkow and Fowler 2000).
Researchers have suggested that repeated alcohol use gradually enhances incentive salience and craving response toward alcoholic beverages by altering the reward pathways and triggering more alcohol craving and drug seeking (Breese et al. 2011; Robinson and Berridge 1993). Altered reward-system function, in turn, could further aggravate a lack of control over the reward response and intensify alcohol craving and the urge to drink alcohol, both of which are associated with increased vulnerability to alcohol relapse (Breese et al. 2011; Sinha 2008). Several lines of research support this theory, reporting significant associations between altered striatal response and alcohol relapse:
- Decreased levels of striatal dopamine D2 receptor persisted in AUD patients and did not recover up to 4 months after alcohol detoxification (Volkow et al. 2002).
- Patients who relapsed within 3 months after discharge had lower levels of dopamine during detoxification than patients who did not relapse, according to a study that measured dopamine in 21 AUD inpatients using [123I] iodobenzamide (IBZM) single-photon emission computerized tomography (SPECT) (Guardia et al. 2000).
- AUD patients who relapsed within 3 months of becoming abstinent showed increased activity in part of the striatum, called the ventral putamen, when viewing visual alcohol cues during the early weeks of abstinence (at least 1 week after detoxification) (Braus et al. 2001).
- On the other hand, recently detoxified (1 to 3 weeks) alcoholic patients with a blunted striatal response to positive emotional pictures relative to neutral pictures had a greater number of drinking days and a higher amount of alcohol consumed during the 6-month followup (Heinz et al. 2007).
These studies suggest that striatal reward system function plays a key role in the development of alcoholism and continues to influence the course of alcoholism by affecting alcohol recovery. Continued alcohol use seems to sensitize striatal reward function and increase incentive salience toward alcohol stimuli. In AUD patients, this altered striatal system may further intensify craving responses and trigger withdrawal symptoms during alcohol-free periods, increasing risk for relapse (Vanderschuren and Pierce 2010).
Neuroadaptations in the Neural Circuit of Stress Modulation
As excessive alcohol use continues, alterations in the reward system could result in allostatic changes in other brain regions closely connected with the striatum, including the limbic regions and the PFC (Breese et al. 2011; Koob and Volkow 2010). In particular, alterations in the stress system may play a crucial role in the well-known comorbid symptoms associated with alcohol dependence, including aversive emotional states such as anxiety, negative mood, high stress sensitivity, and stress-induced alcohol craving (for example, see Sinha et al. 2009).
Stress is a critical factor in increasing alcohol craving and compulsive alcohol consumption (Breese et al. 2005; Koob 2009), as evidenced by both preclinical and clinical studies, including overconsumption of alcohol in male mice with prenatal stress (Campbell et al. 2009), early trauma associated with greater alcohol use and alcohol craving (Schumache et al. 2006), and increased alcohol use after the 9/11 terrorist attacks among New York City residents (Vlahov et al. 2006). Individuals suffering from chronic alcoholism frequently report high stress sensitivity and stress-triggered intense craving (Fox et al. 2007; Sinha et al. 2009). And stress sensitivity plays a crucial role in increased alcohol craving to alleviate aversive emotions or stimuli (Gilpin and Koob 2008)—known as “negatively reinforced craving”—which becomes a main driving force for drinking as excessive alcohol use continues (Koob 2009; Koob et al. 2004; Sinha 2008).
The brain’s stress response involves activation of the ANS and HPA axis systems to promote regulation of physiological arousal and also facilitate adaptive coping (Sinha 2008). Chronic alcoholism is associated with impaired autonomic regulation characterized by high basal heart rate, reduced heart rate variability, and increased blood pressure (Quintana et al. 2013; Sinha et al. 2009; Stormark et al. 1998; Thayer et al. 2006). Further, upregulated HPA axis function, including elevated levels of basal cortisol and adreno-corticotrophic hormone (ACTH), has been frequently found in people with AUD (Breese et al. 2011; Sinha 2008; Sinha et al. 2009). Consistent with this, alcoholics who continue to drink, and those experiencing withdrawal symptoms, have increased levels of basal stress hormones, including cortisol, norepinephrine, and corticotropin-releasing factor (CRF) (for review, see Breese et al. 2011). In addition, a study of 93 treatment-engaged, 1-month-abstinent AUD patients found strong associations between alcohol relapse and HPA axis system function. In this study, greater morning adrenal sensitivity indexed by the cortisol-to-ACTH ratio significantly predicted a shorter time to future initial relapse as well as heavy-drinking relapse (Sinha et al. 2011), indicating a significant role of chronic alcohol-related stress pathology in alcohol recovery.
In terms of brain regions involved, researchers postulate that neuroadaptations in the amygdala may influence negatively reinforced craving and alcohol seeking (Koob 2009; Koob et al. 2004; Sinha 2008). The amygdala is involved in stress-induced physiological responses via modulation of CRF and norepinephrine pathways, which are well known for their contribution to negative reinforcement aspects of addiction (Koob 1999, 2009). Research with AUD patients abstinent for 1 week shows a potential role of altered amygdala functioning in alcohol recovery. In this study, patients who relapsed had reduced amygdala volume compared with patients who did not relapse, and the reduction of the amygdala volume was significantly associated with alcohol craving and the amount of follow-up alcohol drinking (Wrase et al. 2008). Consistent with these data, preclinical studies report associations between altered response in the extended amygdala and stress-primed drug reinstatement (for review, see Kalivas and McFarland 2003).
During stress, ANS and HPA axis function are under the regulatory control of the VmPFC (Figueiredo et al. 2003; Radley 2006). Preclinical studies demonstrate decreased HPA axis response to stress following VmPFC lesions (Radley 2006) and find that the VmPFC maintains stress-related inhibitory control over HPA axis arousal (Figueiredo et al. 2003). In addition, a meta-analysis of studies in humans reported significant associations between brain activity in the VmPFC and amygdala and ANS function indexed by heart rate variability (Thayer et al. 2012). Given that chronic alcoholism is associated with HPA axis and ANS system dysfunctions, as discussed earlier, these findings on the VmPFC regulation over stress- related HPA axis and ANS arousal suggest that individuals with chronic alcoholism may have underlying VmPFC dysfunction in response to stress. Consistent with this hypothesis, a recent fMRI study (Seo et al. 2013) found lowered activity in the stress modulatory regions involving VmPFC/ ACC during stress exposure in 30 AUD patients engaged in inpatient treatment and abstinent for 4 weeks, compared with 30 matched healthy control subjects (figure 1A). Interestingly, the researchers observed an opposite pattern when the subjects were relaxed: AUD patients showed hyperactive VmPFC/ACC compared with control subjects (figure 1A). More importantly, to prospectively assess relapse and early recovery, these researchers followed the same 30 AUD patients, plus 15 others, after they completed inpatient treatment. Results indicated that lowered VmPFC activity in response to stress exposure relative to the response when patients were relaxed was significantly associated with stress-induced alcohol craving and also predicted a shorter time to future relapse (see figure 1B) (Seo et al. 2013). In addition, lower VmPFC activity and insula response to stress was significantly correlated with more days of alcohol use during subsequent followup, emphasizing the contribution of altered stress neural circuitry to relapse susceptibility (Seo et al. 2013).
Although further work still is needed to fully understand the associations between stress-related neural response during abstinence, treatment, and early alcohol recovery, available data suggest that neuroadaptations in the peripheral and CNS involved in stress modulation play a significant role in recovery from chronic alcoholism. Altered emotional and stress responses and poor abilities to cope under stress observed in people with AUD may increase vulnerability to high-stress–related craving, relapse, and alcohol drinking, especially under challenging life circumstances.
PFC Regulatory Function in Alcohol Recovery
If repeated alcohol exposure disrupts the limbic-striatal system, the result could progressively debilitate prefrontal executive functions (Seo and Sinha 2014). Chronic alcohol-related PFC impairments, in turn, can compromise one’s ability to recover from alcoholism by adversely influencing executive function, inhibitory control, and decisionmaking (Bechara 2005; Goldstein and Volkow 2011). Many neuroimaging studies consistently have indicated structural and functional deficits in prefrontal regulatory regions associated with chronic alcoholism (for review, see Buhler and Mann 2011).
Structural imaging studies, for example, find reduced gray matter volume in the medial PFC/OFC and its surrounding regions in AUD patients, and this is associated with poor treatment outcome. One study (Durazzo et al. 2011) examined cortical thickness in people with AUD who averaged 35 to 36 years of lifetime drinking and were seeking treatment. Patients who relapsed by a 12-month followup had decreased cortical thickness, especially in the OFC and right rostral/caudal middle frontal cortex, compared with AUD patients who continued to abstain after 12 months. (Durazzo et al. 2011). In an MRI study that examined AUD patients with an average of 18.6 years of alcohol use, soon after they became abstinent during treatment, patients had decreased brain volume in the gray matter of their medial PFC and posterior parietal-occipital area. At a 3-month followup after treatment, the researchers found that the degree of volume reductions significantly predicted a shorter time to initial relapse as well as heavy-drinking relapse, even after controlling for years of alcohol use and baseline alcohol intake (Rando et al. 2011). Furthermore, a study investigating both structural and functional patterns in detoxified AUD patients found that patients who relapsed within 3 months after completing treatment showed atrophy in regions of OFC and right medial PFC and ACC compared with patients who did not relapse. Relapsed patients also showed increased alcohol cue–induced activation in the left medial PFC regions in this study (Beck et al. 2012).
Functional neuroimaging studies also have reported connections between alcoholism, alcohol recovery, and altered activity in the medial PFC, OFC, and striatum. In AUD individuals, PET imaging studies found decreased glucose metabolism in the frontal cortex during alcohol withdrawal (for review, see Volkow and Fowler 2000) and reduced availability in striatal D2 receptors associated with lowered OFC/ACC function (Volkow et al. 2007). A study performing a 3-month followup on alcohol-dependent patients who had been abstinent for an average of 7 weeks prior to the start of the study, found that the five patients who relapsed showed pronounced activity in the medial PFC, ACC, and striatum when they viewed alcohol pictures. In these patients, there was a significant association between medial PFC activity and the amount of subsequent alcohol consumption (Grusser et al. 2004). Another study used SPECT to study brain blood flow in AUD inpatients at the end of an alcohol detoxification program that lasted at least 7 days. The nine patients who relapsed 2 months later displayed decreased blood flow in the medial frontal lobe and poor working-memory performance relative to 11 abstainers. The working-memory deficits were associated with low blood flow in the medial frontal lobe (Noel et al. 2002). These neuroimaging studies point to a potential significant role of structural and functional neuroplasticity in the prefrontal regulatory regions involving the medial PFC, OFC, and ACC in increased relapse risk and poor alcohol recovery.
Neuronal Hyperexcitability and Alcohol Recovery
Recent evidence in humans suggests that excessive, chronic alcohol consumption may lead to hyperexcitability of neurons in the CNS, which, in turn, plays a role in alcohol addiction and recovery (Porjesz and Begleiter 2003; Seo et al. 2013; Sinha et al. 2011). Indeed, studies have found hyperactive CNS and electroencephalogram (EEG) responses in people with AUD, including increased excitatory neurotransmission associated with long-term alcohol use and hyperactive EEG responses in the frontal regulatory regions (Bauer 2001; Porjesz and Begleiter 2003). Studies also have found that alcohol-related neuronal adaptations on basal-state physiology, including upregulated ANS and HPA axis systems, underlie high alcohol craving, poor clinical outcome, and relapse vulnerability by disrupting physiological arousal (Breese et al. 2011; Seo et al. 2013; Sinha et al. 2011). In addition, a recent fMRI study found significant associations between hyperactive brain response during a relaxed state and susceptibility to alcohol craving and relapse in AUD patients who were engaged in treatment and 4 to 8 weeks abstinent. In this study, hyperactivity during relaxation in the VmPFC/ACC, but no other region, was associated with greater alcohol craving when subjects were presented with alcohol cues (figure 2A). In addition, the VmPFC/ACC hyperactivity predicted a shorter time to subsequent initial relapse and heavy-drinking relapse (figure 2B), as well as more alcohol use during a 90-day follow-up period (Seo et al. 2013). These findings highlight the important role of basal-state hyperactivity and integrity of VmPFC function in recovery from chronic alcoholism.
Conclusion and Future Directions
Alcoholism is a chronic illness, characterized by high relapse risk. Research now suggests that underlying this chronic relapse risk may be negative neuroplastic changes in the brain caused by the cycle of continued alcohol abuse and repeated brief alcohol abstinence and/or alcohol withdrawal. These neuroplastic changes occur in the PSL circuit, which regulates emotions and decisionmaking, which, in turn, influence alcohol recovery (Bechara 2005; Everitt and Robbins 2005; Goldstein and Volkow 2011). Within the PSL circuit, the PFC regulates limbic and striatal regions to modulate emotional and physiological responses to various reward- and stress-related stimuli (Seo and Sinha 2014). In individuals with chronic alcoholism, persistent sensitization of subcortical limbic-striatal regions from prolonged alcohol use could compromise the PFC regulatory function, resulting in difficulties in emotional regulation, poor impulse control, and high alcohol craving. Substantially weakened PFC function could, in turn, further disinhibit limbic-striatal responses especially under challenging situations, including stress and exposure to alcohol-related cues. In addition, given the crucial role of the PFC in inhibitory control and decisionmaking (Bechara 2005; Goldstein and Volkow 2011), altered PFC function could result in an inability to inhibit compulsive alcohol seeking and poor decisionmaking when confronted with the choice to return to drinking and continued alcohol use despite negative consequences, thereby aggravating the relapse cycle.
The evidence supporting a role of the neuroadaptative changes in the PSL circuit in alcohol recovery points to important clinical implications:
- The neuroadaptive patterns in this circuit may serve as a set of neurobiological markers of alcohol relapse and recovery. Future research can validate these patterns and investigate their use to help predict relapse vulnerability and to identify people with the greatest challenge to alcohol recovery in the clinical setting.
- Researchers could develop and test novel treatment strategies that target these validated biomarkers and attempt to reverse these neuroadaptations and significantly improve the chances of recovery from alcoholism. Already evidence supports a mediating role of neuroplasticity in the PSL circuit in improving treatment outcome. A study (Muller et al. 2009) with deep brain stimulation showed the effectiveness of this method in recovering ventral striatal function in AUD individuals. In addition, a recent fMRI study (Brewer et al. 2011) showed that meditators with mindfulness training experience have stable VmPFC and posterior cingulate cortex activity compared with control subjects as well as stronger connectivity between cingulate cortex and dorsolateral PFC, suggesting that mindfulness training may hold potential for treating alcoholism. Consistent with these data, a recent clinical outcome study (Bowen et al. 2014) reported that participants assigned to a mindfulness-based relapse prevention program had fewer days of drug use and decreased heavy drinking, compared with cognitive–behavioral relapse prevention or 12-step–based program approaches at a12-month followup.
- Researchers could develop treatments that target withdrawal symptoms and stress-related pathology, such as stress-induced craving and alcohol seeking, implicated by the alcohol-related neuroadaptations in the PSL circuit. For instance, alpha1-adrenergic antagonists, such as Prazosin, show promise for improving stress-induced deficits and impaired PFC function from chronic stress (for a review, see Arnsten 2009). This drug also reduces alcohol withdrawal symptoms and stress-related alcohol seeking in animals (Kukolja et al. 2011; Walker et al. 2008) and improves stress and alcohol cue–induced craving and alcohol use outcomes in humans (Fox et al. 2012; Simpson et al. 2009). Alternative medicines, such as herbal remedies, are another area of interest. For example, Ge Gen (Kudzu root, Rx. Pueriariae), an herbal remedy frequently used in Eastern medicine, is effective in controlling alcohol intake and alcohol-related withdrawal symptoms (Benlhabib et al. 2004; Lukas et al. 2005). Studies that examine whether the treatments can restore PSL circuit function, especially the VmPFC, and improve alcoholism recovery rates, would be beneficial.
In conclusion, current neurobiological research in humans has identified neuroplasticity in the PSL circuit and its related dysfunctions as key factors increasing relapse risk and jeopardizing alcohol recovery. Further development of biomarkers for these alcohol-related neuroadaptive changes and new treatments that aim to restore the brain have the potential to influence the development of new treatment strategies to promote alcohol recovery and reduce the global burden associated with alcoholism.
This work was supported by National Institutes of Health grants R01–AA– 013892, R01–AA–20504, R01–AA– 20095, UL1–RR–024139, and the NIH Common Fund grant UL1–DE– 19856, PL1–DA–024859.
The authors declare that they have no competing financial interests.
Arnsten, A.F. Stress signalling pathways that impair prefrontal cortex structure and function. Nature Reviews. Neuroscience 10(6):410–422, 2009. PMID: 19455173
Bauer, L.O. Predicting relapse to alcohol and drug abuse via quantitative electroencephalography. Neuropsychopharmacology 25(3):332–340, 2001. PMID: 11522462
Bechara, A. Decision making, impulse control and loss of willpower to resist drugs: A neurocognitive perspective. Nature Neuroscience 8(11):1458–1463, 2005. PMID: 16251988
Beck, A.; Wustenberg, T.; Genauck, A.; et al. Effect of brain structure, brain function, and brain connectivity on relapse in alcohol-dependent patients. Archives of General Psychiatry 69(8):842–852, 2012. PMID: 22868938
Benlhabib, E.; Baker, J.I.; Keyler, D.E.; and Singh, A.K. Kudzu root extract suppresses voluntary alcohol intake and alcohol withdrawal symptoms in P rats receiving free access to water and alcohol. Journal of Medicinal Food 7(2):168–179, 2004. PMID: 15298764
Bowen, S.; Witkiewitz, K.; Clifasefi, S.L.; et al. Relative efficacy of mindfulness-based relapse prevention, standard relapse prevention, and treatment as usual for substance use disorders: A randomized clinical trial. JAMA Psychiatry 71(5):547–556, 2014. PMID: 24647726
Braus, D.F.; Wrase, J.; Grusser, S.; et al. Alcohol-associated stimuli activate the ventral striatum in abstinent alcoholics. Journal of Neural Transmission 108(7): 887–894, 2001. PMID: 11515754
Breese, G.R.; Overstreet, D.H.; and Knapp, D.J. Conceptual framework for the etiology of alcoholism: A “kindling”/stress hypothesis. Psychopharmacology (Berlin) 178(4): 367–380, 2005. PMID: 15765253
Breese, G.R.; Sinha, R.; and Heilig, M. Chronic alcohol neuroadaptation and stress contribute to susceptibility for alcohol craving and relapse. Pharmacology & Therapeutics 129(2):149–171, 2011. PMID: 20951730
Brewer, J.A.; Worhunsky, P.D.; Gray, J.R.; et al. Meditation experience is associated with differences in default mode network activity and connectivity. Proceedings of the National Academy of Sciences of the United States of America 108(50):20254–20259, 2011. PMID: 22114193
Buhler, M., and Mann, K. Alcohol and the human brain: A systematic review of different neuroimaging methods. Alcoholism: Clinical and Experimental Research 35(10):1771–1793, 2011. PMID: 21777260
Camchong, J.; Stenger, V.A.; and Fein, G. Resting-state synchrony in short-term versus long-term abstinent alcoholics. Alcoholism: Clinical and Experimental Research 37(5):794–803, 2013. PMID: 23421812
Campbell, J.C.; Szumlinski, K.K.; and Kippin, T.E. Contribution of early environmental stress to alcoholism vulnerability. Alcohol 43(7):547–554, 2009. PMID: 19913199
Cohen, B.J. Theory and Practice of Psychiatry. New York: Oxford University Press, 2003
Dawson, D.A.; Grant, B.F.; Stinson, F.S.; et al. Recovery from DSM-IV alcohol dependence: United States, 2001-2002. Addiction 100(3):281–292, 2005. PMID: 15733237
Durazzo, T.C.; Tosun, D.; Buckley, S.; et al. Cortical thickness, surface area, and volume of the brain reward system in alcohol dependence: Relationships to relapse and extended abstinence. Alcoholism: Clinical and Experimental Research 35(6):1187–11200, 2011. PMID: 21410483
Everitt, B.J., and Robbins, T.W. Neural systems of reinforcement for drug addiction: From actions to habits to compulsion. Nature Neuroscience 8(11):1481–1489, 2005. PMID: 16251991
Figueiredo, H.F.; Bruestle, A.; Bodie, B.; et al. The medial prefrontal cortex differentially regulates stress-induced c-fos expression in the forebrain depending on type of stressor. European Journal of Neuroscience 18(8):2357–2364, 2003. PMID: 14622198
Filbey, F.M.; Claus, E.; Audette, A.R.; et al. Exposure to the taste of alcohol elicits activation of the mesocorticolimbic neurocircuitry. Neuropsychopharmacology 33(6):1391–1401, 2008. PMID: 17653109
Fox, H.C.; Anderson, G.M.; Tuit, K.; et al. Prazosin effects on stress- and cue-induced craving and stress response in alcohol-dependent individuals: Preliminary findings. Alcoholism: Clinical and Experimental Research 36(2):351–360, 2012. PMID: 21919922
Fox, H.C.; Bergquist, K.L.; Hong, K.I.; and Sinha, R. Stress-induced and alcohol cue-induced craving in recently abstinent alcohol-dependent individuals. Alcoholism: Clinical and Experimental Research 31(3):395–403, 2007. PMID: 17295723
Gilman, J.M.; Ramchandani, V.A.; Davis, M.B.; et al. Why we like to drink: A functional magnetic resonance imaging study of the rewarding and anxiolytic effects of alcohol. Journal of Neuroscience 28(18):4583–4591, 2008. PMID: 18448634
Gilman, J.M.; Smith, A.R.; Ramchandani, V.A.; et al. The effect of intravenous alcohol on the neural correlates of risky decision making in healthy social drinkers. Addiction Biology 17(2):465–478, 2012. PMID: 21995446
Gilpin, N.W., and Koob, G.F. Neurobiology of alcohol dependence: Focus on motivational mechanisms. Alcohol Research & Health 31(3):185–195, 2008. PMID: 19881886
Goldstein, R.Z., and Volkow, N.D. Dysfunction of the prefrontal cortex in addiction: Neuroimaging findings and clinical implications. Nature Reviews. Neuroscience 12(11):652–669, 2011. PMID: 22011681
Gorka, S.M.; Fitzgerald, D.A.; King, A.C.; and Phan, K.L. Alcohol attenuates amygdala-frontal connectivity during processing social signals in heavy social drinkers: A preliminary pharmaco-fMRI study. Psychopharmacology (Berlin) 229(1):141–154, 2013. PMID: 23584670
Grusser, S.M.; Wrase, J.; Klein, S.; et al. Cue-induced activation of the striatum and medial prefrontal cortex is associated with subsequent relapse in abstinent alcoholics. Psychopharmacology (Berlin) 175(3):296–302, 2004. PMID: 15127179
Guardia, J.; Catafau, A.M.; Batlle, F.; et al. Striatal dopaminergic D(2) receptor density measured by [(123)I]iodobenzamide SPECT in the prediction of treatment outcome of alcohol-dependent patients. American Journal of Psychiatry 157(1):127–129, 2000. PMID: 10618027
Heinz, A.; Wrase, J.; Kahnt, T.; et al. Brain activation elicited by affectively positive stimuli is associated with a lower risk of relapse in detoxified alcoholic subjects. Alcoholism: Clinical and Experimental Research 31(7):1138–1147, 2007. PMID: 17488322
Kalivas, P.W., and McFarland, K. Brain circuitry and the reinstatement of cocaine-seeking behavior. Psychopharmacology (Berlin) 168(1-2):44–56, 2003. PMID: 12652346
Kalivas, P.W., and O’Brien, C. Drug addiction as a pathology of staged neuroplasticity. Neuro-psychopharmacology 33(1):166–180, 2008. PMID: 17805308
Koob, G.F. Corticotropin-releasing factor, norepinephrine, and stress. Biological Psychiatry 46(9):1167–1180, 1999. PMID: 10560023
Koob, G.F. Dynamics of neuronal circuits in addiction: Reward, antireward, and emotional memory. Pharmacopsychiatry 42(Suppl. 1):S32–S41, 2009. PMID: 19434554
Koob, G.F.; Ahmed, S.H.; Boutrel, B.; et al. Neurobiological mechanisms in the transition from drug use to drug dependence. Neuroscience and Biobehavioral Reviews 27(8):739–749, 2004. PMID: 15019424
Koob, G.F., and Volkow, N.D. Neurocircuitry of addiction. Neuropsychopharmacology 35(1):217–238, 2010. PMID: 19710631
Kukolja, J.; Klingmuller, D.; Maier, W.; et al. Noradrenergic-glucocorticoid modulation of emotional memory encoding in the human hippocampus. Psychological Medicine 41(10):2167–2176, 2011. PMID: 21375794
Kushner, M.G.; Abrams, K.; Thuras, P.; et al. Follow-up study of anxiety disorder and alcohol dependence in comorbid alcoholism treatment patients. Alcoholism: Clinical and Experimental Research 29(8):1432–1443, 2005. PMID: 16131851
Lukas, S.E.; Penetar, D.; Berko, J.; et al. An extract of the Chinese herbal root kudzu reduces alcohol drinking by heavy drinkers in a naturalistic setting. Alcoholism: Clinical and Experimental Research 29(5):756–762, 2005. PMID: 15897719
Martinez, D.; Gil, R.; Slifstein, M.; et al. Alcohol dependence is associated with blunted dopamine transmission in the ventral striatum. Biological Psychiatry 58(10):779–786, 2005. PMID: 16018986
Muller, U.J.; Sturm, V.; Voges, J.; et al. Successful treatment of chronic resistant alcoholism by deep brain stimulation of nucleus accumbens: First experience with three cases. Pharmacopsychiatry 42(6):288–291, 2009. PMID: 19924591
Noel, X.; Sferrazza, R.; Van Der Linden, M.; et al. Contribution of frontal cerebral blood flow measured by (99m)Tc-Bicisate spect and executive function deficits to predicting treatment outcome in alcohol-dependent patients. Alcohol and Alcoholism 37(4):347–354, 2002. PMID: 12107037
Porjesz, B., and Begleiter, H. Alcoholism and human electrophysiology. Alcohol Research & Health 27(2):153–160, 2003. PMID: 15303626
Quintana, D.S.; Guastella, A.J.; McGregor, I.S.; et al. Heart rate variability predicts alcohol craving in alcohol dependent outpatients: Further evidence for HRV as a psychophysiological marker of self-regulation. Drug and Alcohol Dependence 132(1-2):395–398, 2013. PMID: 23601925
Radley, J.; Arias, C.; and Sawchenkole P.E. Regional differentiation of the medial prefrontal cortex in regulating adaptive responses to acute emotional stress. Journal of Neuroscience 26(50):12967–12976, 2006. PMID: 17167086
Rando, K.; Hong, K.I.; Bhagwagar, Z.; et al. Association of frontal and posterior cortical gray matter volume with time to alcohol relapse: A prospective study. American Journal of Psychiatry 168(2):183–192, 2011. PMID: 21078704
Robinson, T.E., and Berridge, K.C. The neural basis of drug craving: An incentive-sensitization theory of addiction. Brain Research. Brain Research Reviews 18(3):247–291, 1993. PMID: 8401595
Sale, A.; Berardi, N.; and Maffei, L. Environment and brain plasticity: Towards an endogenous pharmacotherapy. Physiological Reviews 94(1):189–234, 2014. PMID: 24382886
Schumacher, J.A.; Coffey, S.F.; and Stasiewicz, P.R. Symptom severity, alcohol craving, and age of trauma onset in childhood and adolescent trauma survivors with comorbid alcohol dependence and posttraumatic stress disorder. American Journal on Addictions 15(6):422–425, 2006. PMID: 17182443
Seo, D.; Jia, Z.; Lacadie, C.M.; et al. Sex differences in neural responses to stress and alcohol context cues. Human Brain Mapping 32(11):1998–2013, 2011. PMID: 21162046
Seo, D.; Lacadie, C.M.; Tuit, K.; et al. Disrupted ventromedial prefrontal function, alcohol craving, and subsequent relapse risk. JAMA Psychiatry 70(7):727–739, 2013. PMID: 23636842
Seo, D., and Sinha, R. Prefrontal limbic-striatal circuits and alcohol addiction in humans. In: Noronha, A.B.; Cui, C.; Harris, A.; and Crabbe, J.C.; Eds. Neurobiology of Alcohol Dependence. London: Academic Press, Elsevier Science, 2014, pp. 49–59.
Shaham, Y., and Hope, B.T. The role of neuroadaptations in relapse to drug seeking. Nature Neuroscience 8(11):1437–1439, 2005. PMID: 16251983
Simpson, T.L.; Saxon, A.J.; Meredith, C.W.; et al. A pilot trial of the alpha-1 adrenergic antagonist, prazosin, for alcohol dependence. Alcoholism: Clinical and Experimental Research 33(2):255–263, 2009. PMID: 18945226
Sinha, R. Chronic stress, drug use, and vulnerability to addiction. Annals of the New York Academy of Sciences 1141:105–130, 2008. PMID: 18991954
Sinha, R.; Fox, H.C.; Hong, K.A.; et al. Enhanced negative emotion and alcohol craving, and altered physiological responses following stress and cue exposure in alcohol dependent individuals. Neuropsychopharma-cology 34(5):1198–1208, 2009. PMID: 18563062
Sinha, R.; Fox, H.C.; Hong, K.I.; et al. Effects of adrenal sensitivity, stress- and cue-induced craving, and anxiety on subsequent alcohol relapse and treatment outcomes. Archives of General Psychiatry 68(9):942–952, 2011. PMID: 21536969
Soderlund, H.; Grady, C.L.; Easdon, C.; and Tulving, E. Acute effects of alcohol on neural correlates of episodic memory encoding. NeuroImage 35(2):928–939, 2007. PMID: 17303439
Sripada, C.S.; Angstadt, M.; McNamara, P.; et al. Effects of alcohol on brain responses to social signals of threat in humans. NeuroImage 55(1):371–380, 2011. PMID: 21122818
Stormark, K.M.; Laberg, J.C.; Nordby, H.; and Hugdahl, K. Heart rate responses indicate locked-in attention in alcoholics immediately prior to drinking. Addictive Behaviors 2392):251–255, 1998. PMID: 9573428
Thayer, J.F.; Ahs, F.; Fredrikson, M.; et al. A meta-analysis of heart rate variability and neuroimaging studies: Implications for heart rate variability as a marker of stress and health. Neuroscience and Biobehavioral Reviews 36(2):747–756, 2012. PMID: 22178086
Thayer, J.F.; Hall, M.; Sollers, J.J., 3rd; and Fischer, J.E. Alcohol use, urinary cortisol, and heart rate variability in apparently healthy men: Evidence for impaired inhibitory control of the HPA axis in heavy drinkers. International Journal of Psychophysiology 59(3):244–250, 2006. PMID: 16325293
Trifilieff, P., and Martinez, D. Blunted dopamine release as a biomarker for vulnerability for substance use disorders. Biological Psychiatry 76(1):4–5, 2014. PMID: 24925889
Vance, D.E., and Wright, M.A. Positive and negative neuroplasticity: Implications for age-related cognitive declines. Journal of Gerontological Nursing 35(6):11–17; quiz 18–19, 2009. PMID: 19537290
Vanderschuren, L.J., and Pierce, R.C. Sensitization processes in drug addiction. Current Topics in Behavioral Neurosciences 3:179–195, 2010. PMID: 21161753
Vlahov, D.; Galea, S.; Ahern, J.; et al. Alcohol drinking problems among New York City residents after the September 11 terrorist attacks. Substance Use & Misuse 41(9):1295–1311, 2006. PMID: 16861180
Volkow, N.D., and Fowler, J.S. Addiction, a disease of compulsion and drive: Involvement of the orbitofrontal cortex. Cerebral Cortex 10(3):318–325, 2000. PMID: 10731226
Volkow, N.D.; Wang, G.J.; Maynard, L.; et al. Effects of alcohol detoxification on dopamine D2 receptors in alcoholics: A preliminary study. Psychiatry Research 116(3):163–172, 2002. PMID: 12477600
Volkow, N.D.; Wang, G.J.; Telang, F.; et al. Profound decreases in dopamine release in striatum in detoxified alcoholics: Possible orbitofrontal involvement. Journal of Neuroscience 27(46):12700–12706, 2007. PMID: 18003850
Walker, B.M.; Rasmussen, D.D.; Raskind, M.A.; and Koob, G.F. alpha1-noradrenergic receptor antagonism blocks dependence-induced increases in responding for ethanol. Alcohol 42(2):91–97, 2008. PMID: 18358987
Wallner, M., and Olsen, R.W. Physiology and pharmacology of alcohol: The imidazobenzodiazepine alcohol antagonist site on subtypes of GABAA receptors as an opportunity for drug development? British Journal of Pharmacology 154(2):288–298, 2008. PMID: 18278063
Wrase, J.; Makris, N.; Braus, D.F.; et al. Amygdala volume associated with alcohol abuse relapse and craving. American Journal of Psychiatry 165(9):1179–1184, 2008. PMID: 18593776
Wrase, J.; Schlagenhauf, F.; Kienast, T.; et al. Dysfunction of reward processing correlates with alcohol craving in detoxified alcoholics. NeuroImage 35(2):787–794, 2007. PMID: 17291784